MSH NEW

Semaglutide is a medication used to treat type 2 diabetes. It belongs to the class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1 RAs). It works by mimicking the action of a hormone called GLP-1, which helps regulate blood sugar levels by stimulating insulin release and reducing the production of glucagon—a hormone that increases blood sugar.

Semaglutide is typically administered via injection under the skin once a week. Its effectiveness in controlling blood sugar levels has made it a valuable addition to diabetes management. Additionally, it may aid in weight loss due to its impact on appetite regulation and slowing of gastric emptying.

Studies have shown that semaglutide not only helps lower blood sugar levels but also reduces the risk of cardiovascular events in people with type 2 diabetes who have underlying heart conditions. It has been well-tolerated by many patients, but like any medication, it can have side effects such as nausea, vomiting, or diarrhea, especially when starting the treatment.

Before starting semaglutide or any new medication, it's crucial to consult a healthcare professional to understand its benefits, risks, and proper usage for individualized diabetes management.